CA2249354A1

CA2249354A1 - Opsonin-enhanced cells, and methods of modulating an immune response to an antigen

Opsonin-enhanced cells, and methods of modulating an immune response to an antigen Download PDF

Info

Publication number: CA2249354A1
Authority: CA; Canada
Prior art keywords: opsonin; cell; cells; antigen; mammal
Prior art date: 1996-03-28
Legal status : Abandoned

Application number

CA 2249354

Other languages

English (en)

French (fr)

Inventor

Andrew H. Segal

Current Assignee

Whitehead Institute for Biomedical Research

Original Assignee

Individual

Priority date

1996-03-28

Filing date

1997-03-27

Publication date

1997-10-02

1997-03-27 Application filed by Individual filed Critical Individual

1997-10-02 Publication of CA2249354A1 publication Critical patent/CA2249354A1/en

Status Abandoned legal-status Critical Current

Links

108700022034 Opsonin Proteins Proteins 0.000 title claims abstract description 288
239000000427 antigen Substances 0.000 title claims abstract description 229
108091007433 antigens Proteins 0.000 title claims abstract description 227
102000036639 antigens Human genes 0.000 title claims abstract description 227
238000000034 method Methods 0.000 title claims abstract description 89
230000028993 immune response Effects 0.000 title abstract description 15
108020004707 nucleic acids Proteins 0.000 claims abstract description 88
150000007523 nucleic acids Chemical class 0.000 claims abstract description 88
102000039446 nucleic acids Human genes 0.000 claims abstract description 88
239000000203 mixture Substances 0.000 claims abstract description 78
210000004027 cell Anatomy 0.000 claims description 367
230000027455 binding Effects 0.000 claims description 58
108090000623 proteins and genes Proteins 0.000 claims description 56
102000005962 receptors Human genes 0.000 claims description 47
108020003175 receptors Proteins 0.000 claims description 47
102000004169 proteins and genes Human genes 0.000 claims description 33
241000894006 Bacteria Species 0.000 claims description 31
239000012634 fragment Substances 0.000 claims description 30
229960005486 vaccine Drugs 0.000 claims description 30
210000001616 monocyte Anatomy 0.000 claims description 26
241000124008 Mammalia Species 0.000 claims description 25
101000901154 Homo sapiens Complement C3 Proteins 0.000 claims description 24
238000000338 in vitro Methods 0.000 claims description 23
230000000295 complement effect Effects 0.000 claims description 19
150000002632 lipids Chemical class 0.000 claims description 18
230000001717 pathogenic effect Effects 0.000 claims description 18
210000004881 tumor cell Anatomy 0.000 claims description 18
102000004127 Cytokines Human genes 0.000 claims description 17
108090000695 Cytokines Proteins 0.000 claims description 17
239000000872 buffer Substances 0.000 claims description 14
239000003446 ligand Substances 0.000 claims description 13
241000700605 Viruses Species 0.000 claims description 12
244000045947 parasite Species 0.000 claims description 12
108010087870 Mannose-Binding Lectin Proteins 0.000 claims description 10
102000009112 Mannose-Binding Lectin Human genes 0.000 claims description 10
108010067306 Fibronectins Proteins 0.000 claims description 9
102000016359 Fibronectins Human genes 0.000 claims description 9
108060003951 Immunoglobulin Proteins 0.000 claims description 9
102000018358 immunoglobulin Human genes 0.000 claims description 9
108010076504 Protein Sorting Signals Proteins 0.000 claims description 8
102100033312 Alpha-2-macroglobulin Human genes 0.000 claims description 7
108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 claims description 7
238000012986 modification Methods 0.000 claims description 7
108010018927 conglutinin Proteins 0.000 claims description 6
QCUFYOBGGZSFHY-UHFFFAOYSA-N depsidomycin Chemical compound O=C1C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(NC=O)C(C)CC)C(C)OC(=O)C2CCCNN2C(=O)C(CC(C)C)NC(=O)C2CCCNN21 QCUFYOBGGZSFHY-UHFFFAOYSA-N 0.000 claims description 6
229940072221 immunoglobulins Drugs 0.000 claims description 6
239000004094 surface-active agent Substances 0.000 claims description 6
108010078015 Complement C3b Proteins 0.000 claims description 5
239000001963 growth medium Substances 0.000 claims description 5
239000002523 lectin Substances 0.000 claims description 5
102000004856 Lectins Human genes 0.000 claims description 4
108090001090 Lectins Proteins 0.000 claims description 4
101100006976 Mus musculus C4b gene Proteins 0.000 claims description 4
239000003937 drug carrier Substances 0.000 claims description 4
241000233866 Fungi Species 0.000 claims description 3
238000003776 cleavage reaction Methods 0.000 claims description 3
108010052926 complement C3d,g Proteins 0.000 claims description 3
230000007017 scission Effects 0.000 claims description 3
150000007970 thio esters Chemical class 0.000 claims description 3
210000002950 fibroblast Anatomy 0.000 claims description 2
210000002510 keratinocyte Anatomy 0.000 claims description 2
201000011510 cancer Diseases 0.000 claims 4
230000002238 attenuated effect Effects 0.000 claims 1
210000003527 eukaryotic cell Anatomy 0.000 claims 1
210000001236 prokaryotic cell Anatomy 0.000 claims 1
210000000612 antigen-presenting cell Anatomy 0.000 description 56
238000003556 assay Methods 0.000 description 51
241000699670 Mus sp. Species 0.000 description 45
150000001413 amino acids Chemical class 0.000 description 36
241001465754 Metazoa Species 0.000 description 34
206010028980 Neoplasm Diseases 0.000 description 32
235000018102 proteins Nutrition 0.000 description 30
230000001580 bacterial effect Effects 0.000 description 27
230000004044 response Effects 0.000 description 27
102100022133 Complement C3 Human genes 0.000 description 24
239000000047 product Substances 0.000 description 21
230000003612 virological effect Effects 0.000 description 20
235000001014 amino acid Nutrition 0.000 description 19
239000002953 phosphate buffered saline Substances 0.000 description 19
108090000765 processed proteins & peptides Proteins 0.000 description 19
241000699666 Mus <mouse, genus> Species 0.000 description 17
108010074051 C-Reactive Protein Proteins 0.000 description 16
102100032752 C-reactive protein Human genes 0.000 description 16
239000012981 Hank's balanced salt solution Substances 0.000 description 16
238000001727 in vivo Methods 0.000 description 15
229920001184 polypeptide Polymers 0.000 description 15
102000004196 processed proteins & peptides Human genes 0.000 description 15
241000282320 Panthera leo Species 0.000 description 12
210000001744 T-lymphocyte Anatomy 0.000 description 12
230000002538 fungal effect Effects 0.000 description 12
150000004676 glycans Chemical class 0.000 description 12
229920001282 polysaccharide Polymers 0.000 description 12
239000005017 polysaccharide Substances 0.000 description 12
239000011734 sodium Substances 0.000 description 12
238000012546 transfer Methods 0.000 description 12
108020004414 DNA Proteins 0.000 description 11
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 11
238000002474 experimental method Methods 0.000 description 11
-1 C3d Proteins 0.000 description 10
230000005875 antibody response Effects 0.000 description 10
239000002299 complementary DNA Substances 0.000 description 10
239000002773 nucleotide Substances 0.000 description 10
125000003729 nucleotide group Chemical group 0.000 description 10
210000002966 serum Anatomy 0.000 description 10
239000000243 solution Substances 0.000 description 10
210000001519 tissue Anatomy 0.000 description 10
201000009030 Carcinoma Diseases 0.000 description 9
102000004405 Collectins Human genes 0.000 description 9
108090000909 Collectins Proteins 0.000 description 9
206010057249 Phagocytosis Diseases 0.000 description 9
241000233872 Pneumocystis carinii Species 0.000 description 9
239000002253 acid Substances 0.000 description 9
210000003719 b-lymphocyte Anatomy 0.000 description 9
239000011324 bead Substances 0.000 description 9
238000010790 dilution Methods 0.000 description 9
239000012895 dilution Substances 0.000 description 9
238000009472 formulation Methods 0.000 description 9
210000002540 macrophage Anatomy 0.000 description 9
230000008782 phagocytosis Effects 0.000 description 9
230000001177 retroviral effect Effects 0.000 description 9
150000002500 ions Chemical class 0.000 description 8
239000000463 material Substances 0.000 description 8
230000000242 pagocytic effect Effects 0.000 description 8
239000000725 suspension Substances 0.000 description 8
230000009261 transgenic effect Effects 0.000 description 8
241001430294 unidentified retrovirus Species 0.000 description 8
238000011144 upstream manufacturing Methods 0.000 description 8
239000013598 vector Substances 0.000 description 8
241001529936 Murinae Species 0.000 description 7
108700019146 Transgenes Proteins 0.000 description 7
241000223105 Trypanosoma brucei Species 0.000 description 7
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 7
230000000694 effects Effects 0.000 description 7
230000006870 function Effects 0.000 description 7
238000001890 transfection Methods 0.000 description 7
241000701161 unidentified adenovirus Species 0.000 description 7
229920000936 Agarose Polymers 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
210000000712 G cell Anatomy 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
239000002671 adjuvant Substances 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
210000002889 endothelial cell Anatomy 0.000 description 6
239000011521 glass Substances 0.000 description 6
210000004185 liver Anatomy 0.000 description 6
239000013612 plasmid Substances 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
238000012360 testing method Methods 0.000 description 6
239000013603 viral vector Substances 0.000 description 6
102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 5
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 5
241000283973 Oryctolagus cuniculus Species 0.000 description 5
241000700159 Rattus Species 0.000 description 5
206010043376 Tetanus Diseases 0.000 description 5
210000001015 abdomen Anatomy 0.000 description 5
239000004480 active ingredient Substances 0.000 description 5
230000001464 adherent effect Effects 0.000 description 5
244000052616 bacterial pathogen Species 0.000 description 5
210000004369 blood Anatomy 0.000 description 5
239000008280 blood Substances 0.000 description 5
210000000170 cell membrane Anatomy 0.000 description 5
239000003085 diluting agent Substances 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
238000010348 incorporation Methods 0.000 description 5
238000011534 incubation Methods 0.000 description 5
210000000265 leukocyte Anatomy 0.000 description 5
238000005259 measurement Methods 0.000 description 5
230000004048 modification Effects 0.000 description 5
210000000287 oocyte Anatomy 0.000 description 5
230000035755 proliferation Effects 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
230000004083 survival effect Effects 0.000 description 5
238000002255 vaccination Methods 0.000 description 5
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 4
101100334524 Homo sapiens FCGR3B gene Proteins 0.000 description 4
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
206010020751 Hypersensitivity Diseases 0.000 description 4
108090000978 Interleukin-4 Proteins 0.000 description 4
102000004388 Interleukin-4 Human genes 0.000 description 4
102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 4
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 4
239000012980 RPMI-1640 medium Substances 0.000 description 4
206010037742 Rabies Diseases 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
230000004913 activation Effects 0.000 description 4
208000026935 allergic disease Diseases 0.000 description 4
210000001132 alveolar macrophage Anatomy 0.000 description 4
238000013459 approach Methods 0.000 description 4
239000006285 cell suspension Substances 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
239000007822 coupling agent Substances 0.000 description 4
230000002950 deficient Effects 0.000 description 4
238000004925 denaturation Methods 0.000 description 4
230000036425 denaturation Effects 0.000 description 4
DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 4
201000010099 disease Diseases 0.000 description 4
210000003743 erythrocyte Anatomy 0.000 description 4
108020001507 fusion proteins Proteins 0.000 description 4
102000037865 fusion proteins Human genes 0.000 description 4
238000003306 harvesting Methods 0.000 description 4
239000005556 hormone Substances 0.000 description 4
229940088597 hormone Drugs 0.000 description 4
210000000987 immune system Anatomy 0.000 description 4
239000002502 liposome Substances 0.000 description 4
108010022177 mannose binding protein A Proteins 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
230000001404 mediated effect Effects 0.000 description 4
239000012528 membrane Substances 0.000 description 4
210000004379 membrane Anatomy 0.000 description 4
238000000386 microscopy Methods 0.000 description 4
210000002741 palatine tonsil Anatomy 0.000 description 4
239000008188 pellet Substances 0.000 description 4
230000010076 replication Effects 0.000 description 4
230000000241 respiratory effect Effects 0.000 description 4
239000000523 sample Substances 0.000 description 4
239000000126 substance Substances 0.000 description 4
229960000814 tetanus toxoid Drugs 0.000 description 4
230000001225 therapeutic effect Effects 0.000 description 4
229940104230 thymidine Drugs 0.000 description 4
238000005406 washing Methods 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
241000193738 Bacillus anthracis Species 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
241000283707 Capra Species 0.000 description 3
229920002307 Dextran Polymers 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
238000002965 ELISA Methods 0.000 description 3
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 3
208000001382 Experimental Melanoma Diseases 0.000 description 3
102000002702 GPI-Linked Proteins Human genes 0.000 description 3
108010043685 GPI-Linked Proteins Proteins 0.000 description 3
102000003735 Mesothelin Human genes 0.000 description 3
108090000015 Mesothelin Proteins 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
239000004365 Protease Substances 0.000 description 3
108010007127 Pulmonary Surfactant-Associated Protein D Proteins 0.000 description 3
102100027845 Pulmonary surfactant-associated protein D Human genes 0.000 description 3
108700008625 Reporter Genes Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
238000000246 agarose gel electrophoresis Methods 0.000 description 3
230000007815 allergy Effects 0.000 description 3
239000011575 calcium Substances 0.000 description 3
229910052791 calcium Inorganic materials 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
230000032823 cell division Effects 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
238000000576 coating method Methods 0.000 description 3
210000000805 cytoplasm Anatomy 0.000 description 3
230000007547 defect Effects 0.000 description 3
210000004443 dendritic cell Anatomy 0.000 description 3
238000001514 detection method Methods 0.000 description 3
239000003814 drug Substances 0.000 description 3
230000012202 endocytosis Effects 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
239000012894 fetal calf serum Substances 0.000 description 3
239000012530 fluid Substances 0.000 description 3
238000001476 gene delivery Methods 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000009830 intercalation Methods 0.000 description 3
230000002687 intercalation Effects 0.000 description 3
230000005868 ontogenesis Effects 0.000 description 3
239000002243 precursor Substances 0.000 description 3
230000003449 preventive effect Effects 0.000 description 3
241000894007 species Species 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
239000000829 suppository Substances 0.000 description 3
230000001629 suppression Effects 0.000 description 3
238000011282 treatment Methods 0.000 description 3
210000000605 viral structure Anatomy 0.000 description 3
IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 description 2
239000013607 AAV vector Substances 0.000 description 2
101150058765 BACE1 gene Proteins 0.000 description 2
238000011740 C57BL/6 mouse Methods 0.000 description 2
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
108090000007 Carboxypeptidase M Proteins 0.000 description 2
102100032936 Carboxypeptidase M Human genes 0.000 description 2
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
108010058432 Chaperonin 60 Proteins 0.000 description 2
101710098119 Chaperonin GroEL 2 Proteins 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
108010035532 Collagen Proteins 0.000 description 2
108010028780 Complement C3 Proteins 0.000 description 2
208000011231 Crohn disease Diseases 0.000 description 2
201000004624 Dermatitis Diseases 0.000 description 2
241000168726 Dictyostelium discoideum Species 0.000 description 2
108010009900 Endothelial Protein C Receptor Proteins 0.000 description 2
102100030024 Endothelial protein C receptor Human genes 0.000 description 2
201000008808 Fibrosarcoma Diseases 0.000 description 2
108091022930 Glutamate decarboxylase Proteins 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
241000700721 Hepatitis B virus Species 0.000 description 2
208000009889 Herpes Simplex Diseases 0.000 description 2
208000007514 Herpes zoster Diseases 0.000 description 2
241000228402 Histoplasma Species 0.000 description 2
108010065805 Interleukin-12 Proteins 0.000 description 2
102000013462 Interleukin-12 Human genes 0.000 description 2
206010027406 Mesothelioma Diseases 0.000 description 2
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
201000005702 Pertussis Diseases 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
238000010240 RT-PCR analysis Methods 0.000 description 2
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
206010039491 Sarcoma Diseases 0.000 description 2
208000021386 Sjogren Syndrome Diseases 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
230000006052 T cell proliferation Effects 0.000 description 2
MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
241000193803 Therea Species 0.000 description 2
241000223996 Toxoplasma Species 0.000 description 2
206010052779 Transplant rejections Diseases 0.000 description 2
208000008383 Wilms tumor Diseases 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
108010042591 activated protein C receptor Proteins 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 2
OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 description 2
239000001110 calcium chloride Substances 0.000 description 2
229910001628 calcium chloride Inorganic materials 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
239000000969 carrier Substances 0.000 description 2
150000001768 cations Chemical class 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000003593 chromogenic compound Substances 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
229920001436 collagen Polymers 0.000 description 2
SDZRWUKZFQQKKV-JHADDHBZSA-N cytochalasin D Chemical compound C([C@H]1[C@@H]2[C@@H](C([C@@H](O)[C@H]\3[C@]2([C@@H](/C=C/[C@@](C)(O)C(=O)[C@@H](C)C/C=C/3)OC(C)=O)C(=O)N1)=C)C)C1=CC=CC=C1 SDZRWUKZFQQKKV-JHADDHBZSA-N 0.000 description 2
230000007123 defense Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
206010013023 diphtheria Diseases 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000002158 endotoxin Substances 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
210000002919 epithelial cell Anatomy 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
244000053095 fungal pathogen Species 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
210000003494 hepatocyte Anatomy 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
230000006698 induction Effects 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
108010044426 integrins Proteins 0.000 description 2
102000006495 integrins Human genes 0.000 description 2
230000002147 killing effect Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
206010025135 lupus erythematosus Diseases 0.000 description 2
210000001161 mammalian embryo Anatomy 0.000 description 2
239000003550 marker Substances 0.000 description 2
239000002609 medium Substances 0.000 description 2
201000001441 melanoma Diseases 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
230000003071 parasitic effect Effects 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
210000005259 peripheral blood Anatomy 0.000 description 2
239000011886 peripheral blood Substances 0.000 description 2
PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000002062 proliferating effect Effects 0.000 description 2
239000012460 protein solution Substances 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
230000035939 shock Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
210000002437 synoviocyte Anatomy 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
210000001685 thyroid gland Anatomy 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
YHQZWWDVLJPRIF-JLHRHDQISA-N (4R)-4-[[(2S,3R)-2-[acetyl-[(3R,4R,5S,6R)-3-amino-4-[(1R)-1-carboxyethoxy]-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-3-hydroxybutanoyl]amino]-5-amino-5-oxopentanoic acid Chemical compound C(C)(=O)N([C@@H]([C@H](O)C)C(=O)N[C@H](CCC(=O)O)C(N)=O)C1[C@H](N)[C@@H](O[C@@H](C(=O)O)C)[C@H](O)[C@H](O1)CO YHQZWWDVLJPRIF-JLHRHDQISA-N 0.000 description 1
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
MIJDSYMOBYNHOT-UHFFFAOYSA-N 2-(ethylamino)ethanol Chemical compound CCNCCO MIJDSYMOBYNHOT-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 1
102100022464 5'-nucleotidase Human genes 0.000 description 1
NALREUIWICQLPS-UHFFFAOYSA-N 7-imino-n,n-dimethylphenothiazin-3-amine;hydrochloride Chemical compound [Cl-].C1=C(N)C=C2SC3=CC(=[N+](C)C)C=CC3=NC2=C1 NALREUIWICQLPS-UHFFFAOYSA-N 0.000 description 1
102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
102100033639 Acetylcholinesterase Human genes 0.000 description 1
108010022752 Acetylcholinesterase Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
229940122450 Altered peptide ligand Drugs 0.000 description 1
102000001921 Aminopeptidase P Human genes 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
102000006306 Antigen Receptors Human genes 0.000 description 1
108010083359 Antigen Receptors Proteins 0.000 description 1
208000032467 Aplastic anaemia Diseases 0.000 description 1
101100446590 Arabidopsis thaliana FIM5 gene Proteins 0.000 description 1
240000005528 Arctium lappa Species 0.000 description 1
206010003399 Arthropod bite Diseases 0.000 description 1
108010002913 Asialoglycoproteins Proteins 0.000 description 1
206010003571 Astrocytoma Diseases 0.000 description 1
102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
206010004146 Basal cell carcinoma Diseases 0.000 description 1
208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
101710125089 Bindin Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
208000014644 Brain disease Diseases 0.000 description 1
108010085074 Brevican Proteins 0.000 description 1
102100032312 Brevican core protein Human genes 0.000 description 1
102000003930 C-Type Lectins Human genes 0.000 description 1
108090000342 C-Type Lectins Proteins 0.000 description 1
125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
108010059108 CD18 Antigens Proteins 0.000 description 1
108010009575 CD55 Antigens Proteins 0.000 description 1
102100022002 CD59 glycoprotein Human genes 0.000 description 1
108050007957 Cadherin Proteins 0.000 description 1
102000000905 Cadherin Human genes 0.000 description 1
102100024154 Cadherin-13 Human genes 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
101710167916 Carbonic anhydrase 4 Proteins 0.000 description 1
102100024644 Carbonic anhydrase 4 Human genes 0.000 description 1
206010061005 Cardiac myxoma Diseases 0.000 description 1
101150023426 Ccin gene Proteins 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
108010039939 Cell Wall Skeleton Proteins 0.000 description 1
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
108010009685 Cholinergic Receptors Proteins 0.000 description 1
208000005243 Chondrosarcoma Diseases 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
241000543381 Cliftonia monophylla Species 0.000 description 1
108010021332 Coccidioides antigen 2 Proteins 0.000 description 1
208000015943 Coeliac disease Diseases 0.000 description 1
206010009900 Colitis ulcerative Diseases 0.000 description 1
108010023729 Complement 3d Receptors Proteins 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
206010010741 Conjunctivitis Diseases 0.000 description 1
241000557626 Corvus corax Species 0.000 description 1
240000005109 Cryptomeria japonica Species 0.000 description 1
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
206010012335 Dependence Diseases 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
102000003850 Dipeptidase 1 Human genes 0.000 description 1
208000019872 Drug Eruptions Diseases 0.000 description 1
208000003556 Dry Eye Syndromes Diseases 0.000 description 1
206010013774 Dry eye Diseases 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
206010014612 Encephalitis viral Diseases 0.000 description 1
208000032274 Encephalopathy Diseases 0.000 description 1
101001095863 Enterobacteria phage T4 RNA ligase 1 Proteins 0.000 description 1
101710126487 Envelope glycoprotein B Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
206010014967 Ependymoma Diseases 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
208000006168 Ewing Sarcoma Diseases 0.000 description 1
101150106011 FIM2 gene Proteins 0.000 description 1
101150048576 FIM3 gene Proteins 0.000 description 1
102100037815 Fas apoptotic inhibitory molecule 3 Human genes 0.000 description 1
108010087819 Fc receptors Proteins 0.000 description 1
102000009109 Fc receptors Human genes 0.000 description 1
241000282324 Felis Species 0.000 description 1
102000002464 Galactosidases Human genes 0.000 description 1
108010093031 Galactosidases Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
201000010915 Glioblastoma multiforme Diseases 0.000 description 1
206010018338 Glioma Diseases 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
201000005618 Glomus Tumor Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102000008214 Glutamate decarboxylase Human genes 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
102000005720 Glutathione transferase Human genes 0.000 description 1
108010070675 Glutathione transferase Proteins 0.000 description 1
102000005744 Glycoside Hydrolases Human genes 0.000 description 1
108010031186 Glycoside Hydrolases Proteins 0.000 description 1
108700023372 Glycosyltransferases Proteins 0.000 description 1
102000051366 Glycosyltransferases Human genes 0.000 description 1
208000003084 Graves Ophthalmopathy Diseases 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
108010066705 H-cadherin Proteins 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
241000590002 Helicobacter pylori Species 0.000 description 1
GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
101000878602 Homo sapiens Immunoglobulin alpha Fc receptor Proteins 0.000 description 1
101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 description 1
101000576802 Homo sapiens Mesothelin Proteins 0.000 description 1
101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
241001600072 Hydroides Species 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
108010073816 IgE Receptors Proteins 0.000 description 1
102000009438 IgE Receptors Human genes 0.000 description 1
108010073807 IgG Receptors Proteins 0.000 description 1
102000009490 IgG Receptors Human genes 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108010007403 Immediate-Early Proteins Proteins 0.000 description 1
102100038005 Immunoglobulin alpha Fc receptor Human genes 0.000 description 1
102100034349 Integrase Human genes 0.000 description 1
108010052369 Integrin alphaXbeta2 Proteins 0.000 description 1
108090000174 Interleukin-10 Proteins 0.000 description 1
102000003814 Interleukin-10 Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
208000029523 Interstitial Lung disease Diseases 0.000 description 1
208000009164 Islet Cell Adenoma Diseases 0.000 description 1
208000009319 Keratoconjunctivitis Sicca Diseases 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
102100038609 Lactoperoxidase Human genes 0.000 description 1
108010023244 Lactoperoxidase Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
206010024229 Leprosy Diseases 0.000 description 1
241000209082 Lolium Species 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
HCIHJOTZGZSMLV-UHFFFAOYSA-N Lutinine Natural products O=C1C(=Nc2ccccc2)C=C(Nc3ccccc3)c4ccccc14 HCIHJOTZGZSMLV-UHFFFAOYSA-N 0.000 description 1
108010030317 Macrophage-1 Antigen Proteins 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
101710085938 Matrix protein Proteins 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
241000712079 Measles morbillivirus Species 0.000 description 1
108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
102100039373 Membrane cofactor protein Human genes 0.000 description 1
101710127721 Membrane protein Proteins 0.000 description 1
102100030550 Menin Human genes 0.000 description 1
101710169972 Menin Proteins 0.000 description 1
108010057081 Merozoite Surface Protein 1 Proteins 0.000 description 1
102000014842 Multidrug resistance proteins Human genes 0.000 description 1
101100137555 Mus musculus Prg2 gene Proteins 0.000 description 1
241000187479 Mycobacterium tuberculosis Species 0.000 description 1
102000047918 Myelin Basic Human genes 0.000 description 1
102000055324 Myelin Proteolipid Human genes 0.000 description 1
101710107068 Myelin basic protein Proteins 0.000 description 1
101710094913 Myelin proteolipid protein Proteins 0.000 description 1
208000005927 Myosarcoma Diseases 0.000 description 1
YFONKFDEZLYQDH-OPQQBVKSSA-N N-[(1R,2S)-2,6-dimethyindan-1-yl]-6-[(1R)-1-fluoroethyl]-1,3,5-triazine-2,4-diamine Chemical compound C[C@@H](F)C1=NC(N)=NC(N[C@H]2C3=CC(C)=CC=C3C[C@@H]2C)=N1 YFONKFDEZLYQDH-OPQQBVKSSA-N 0.000 description 1
108700020354 N-acetylmuramyl-threonyl-isoglutamine Proteins 0.000 description 1
208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
241001644525 Nastus productus Species 0.000 description 1
208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 1
102000005348 Neuraminidase Human genes 0.000 description 1
108010006232 Neuraminidase Proteins 0.000 description 1
206010029260 Neuroblastoma Diseases 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
102000011931 Nucleoproteins Human genes 0.000 description 1
108010061100 Nucleoproteins Proteins 0.000 description 1
206010033128 Ovarian cancer Diseases 0.000 description 1
102000016387 Pancreatic elastase Human genes 0.000 description 1
108010067372 Pancreatic elastase Proteins 0.000 description 1
241001631646 Papillomaviridae Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
108010081690 Pertussis Toxin Proteins 0.000 description 1
102000006486 Phosphoinositide Phospholipase C Human genes 0.000 description 1
108010044302 Phosphoinositide phospholipase C Proteins 0.000 description 1
208000007913 Pituitary Neoplasms Diseases 0.000 description 1
241000223960 Plasmodium falciparum Species 0.000 description 1
101710183389 Pneumolysin Proteins 0.000 description 1
229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 1
206010065159 Polychondritis Diseases 0.000 description 1
108091036414 Polyinosinic:polycytidylic acid Proteins 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
208000012654 Primary biliary cholangitis Diseases 0.000 description 1
241000288906 Primates Species 0.000 description 1
108091000054 Prion Proteins 0.000 description 1
102000029797 Prion Human genes 0.000 description 1
206010036774 Proctitis Diseases 0.000 description 1
102100024819 Prolactin Human genes 0.000 description 1
108010057464 Prolactin Proteins 0.000 description 1
101710192141 Protein Nef Proteins 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
201000001263 Psoriatic Arthritis Diseases 0.000 description 1
208000036824 Psoriatic arthropathy Diseases 0.000 description 1
108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 1
102000007615 Pulmonary Surfactant-Associated Protein A Human genes 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
239000012979 RPMI medium Substances 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
208000006265 Renal cell carcinoma Diseases 0.000 description 1
201000000582 Retinoblastoma Diseases 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
241000606651 Rickettsiales Species 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000710799 Rubella virus Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
206010039710 Scleroderma Diseases 0.000 description 1
201000010208 Seminoma Diseases 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
102100038081 Signal transducer CD24 Human genes 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
101001039853 Sonchus yellow net virus Matrix protein Proteins 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
206010042033 Stevens-Johnson syndrome Diseases 0.000 description 1
231100000168 Stevens-Johnson syndrome Toxicity 0.000 description 1
108010091105 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
101710137302 Surface antigen S Proteins 0.000 description 1
230000024932 T cell mediated immunity Effects 0.000 description 1
210000000662 T-lymphocyte subset Anatomy 0.000 description 1
101150052863 THY1 gene Proteins 0.000 description 1
108010017842 Telomerase Proteins 0.000 description 1
208000024313 Testicular Neoplasms Diseases 0.000 description 1
108010055044 Tetanus Toxin Proteins 0.000 description 1
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
241000130764 Tinea Species 0.000 description 1
208000002474 Tinea Diseases 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
102000005937 Tropomyosin Human genes 0.000 description 1
108010030743 Tropomyosin Proteins 0.000 description 1
241000223107 Trypanosoma congolense Species 0.000 description 1
241000223109 Trypanosoma cruzi Species 0.000 description 1
206010070517 Type 2 lepra reaction Diseases 0.000 description 1
201000006704 Ulcerative Colitis Diseases 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
206010046851 Uveitis Diseases 0.000 description 1
206010046914 Vaginal infection Diseases 0.000 description 1
201000008100 Vaginitis Diseases 0.000 description 1
108010059722 Viral Fusion Proteins Proteins 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
108010038900 X-Pro aminopeptidase Proteins 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
102000034337 acetylcholine receptors Human genes 0.000 description 1
229940022698 acetylcholinesterase Drugs 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
102000005421 acetyltransferase Human genes 0.000 description 1
230000009471 action Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
208000009956 adenocarcinoma Diseases 0.000 description 1
108060000200 adenylate cyclase Proteins 0.000 description 1
102000030621 adenylate cyclase Human genes 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
201000005179 adrenal carcinoma Diseases 0.000 description 1
201000005188 adrenal gland cancer Diseases 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
201000009961 allergic asthma Diseases 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
208000030961 allergic reaction Diseases 0.000 description 1
NWMHDZMRVUOQGL-CZEIJOLGSA-N almurtide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)CO[C@@H]([C@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O NWMHDZMRVUOQGL-CZEIJOLGSA-N 0.000 description 1
208000004631 alopecia areata Diseases 0.000 description 1
102000013529 alpha-Fetoproteins Human genes 0.000 description 1
108010026331 alpha-Fetoproteins Proteins 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000003092 anti-cytokine Effects 0.000 description 1
230000001028 anti-proliverative effect Effects 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
208000002399 aphthous stomatitis Diseases 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
201000004982 autoimmune uveitis Diseases 0.000 description 1
230000005784 autoimmunity Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000002146 bilateral effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000006161 blood agar Substances 0.000 description 1
230000037396 body weight Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
208000020670 canker sore Diseases 0.000 description 1
210000000234 capsid Anatomy 0.000 description 1
239000002775 capsule Substances 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
208000002458 carcinoid tumor Diseases 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
210000004520 cell wall skeleton Anatomy 0.000 description 1
230000004700 cellular uptake Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
229960003677 chloroquine Drugs 0.000 description 1
WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
238000010367 cloning Methods 0.000 description 1
229960003920 cocaine Drugs 0.000 description 1
229960001338 colchicine Drugs 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
239000006781 columbia blood agar Substances 0.000 description 1
108010062119 complement 1q receptor Proteins 0.000 description 1
230000000536 complexating effect Effects 0.000 description 1
239000003636 conditioned culture medium Substances 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
101150107440 crl gene Proteins 0.000 description 1
229960004397 cyclophosphamide Drugs 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
230000003436 cytoskeletal effect Effects 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000007423 decrease Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
229960002069 diamorphine Drugs 0.000 description 1
238000001085 differential centrifugation Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
239000012470 diluted sample Substances 0.000 description 1
PSLWZOIUBRXAQW-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC PSLWZOIUBRXAQW-UHFFFAOYSA-M 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000000428 dust Substances 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
208000023965 endometrium neoplasm Diseases 0.000 description 1
210000001163 endosome Anatomy 0.000 description 1
108700004025 env Genes Proteins 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical group NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
108020005243 folate receptor Proteins 0.000 description 1
102000006815 folate receptor Human genes 0.000 description 1
230000003325 follicular Effects 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
238000002825 functional assay Methods 0.000 description 1
210000000232 gallbladder Anatomy 0.000 description 1
210000000973 gametocyte Anatomy 0.000 description 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
206010017758 gastric cancer Diseases 0.000 description 1
208000010749 gastric carcinoma Diseases 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
208000005017 glioblastoma Diseases 0.000 description 1
229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229940046528 grass pollen Drugs 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
230000010370 hearing loss Effects 0.000 description 1
231100000888 hearing loss Toxicity 0.000 description 1
208000016354 hearing loss disease Diseases 0.000 description 1
210000002216 heart Anatomy 0.000 description 1
229940037467 helicobacter pylori Drugs 0.000 description 1
230000002008 hemorrhagic effect Effects 0.000 description 1
208000006359 hepatoblastoma Diseases 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
230000008348 humoral response Effects 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
235000011167 hydrochloric acid Nutrition 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
229960002591 hydroxyproline Drugs 0.000 description 1
230000002519 immonomodulatory effect Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
108010075597 immunoglobulin M receptor Proteins 0.000 description 1
230000000415 inactivating effect Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
230000000937 inactivator Effects 0.000 description 1
239000000411 inducer Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000015788 innate immune response Effects 0.000 description 1
210000005007 innate immune system Anatomy 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
230000005865 ionizing radiation Effects 0.000 description 1
PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 1
PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 1
201000004614 iritis Diseases 0.000 description 1
210000004153 islets of langerhan Anatomy 0.000 description 1
238000002955 isolation Methods 0.000 description 1
JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
230000000366 juvenile effect Effects 0.000 description 1
206010023332 keratitis Diseases 0.000 description 1
201000010666 keratoconjunctivitis Diseases 0.000 description 1
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000002372 labelling Methods 0.000 description 1
229940057428 lactoperoxidase Drugs 0.000 description 1
239000008101 lactose Substances 0.000 description 1
210000001821 langerhans cell Anatomy 0.000 description 1
201000005264 laryngeal carcinoma Diseases 0.000 description 1
239000010410 layer Substances 0.000 description 1
229940039781 leptin Drugs 0.000 description 1
201000011486 lichen planus Diseases 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
125000003473 lipid group Chemical group 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
229920006008 lipopolysaccharide Polymers 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
239000006194 liquid suspension Substances 0.000 description 1
150000004668 long chain fatty acids Chemical class 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
201000005296 lung carcinoma Diseases 0.000 description 1
210000005265 lung cell Anatomy 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000007620 mathematical function Methods 0.000 description 1
210000003622 mature neutrocyte Anatomy 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
238000001471 micro-filtration Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
229960005225 mifamurtide Drugs 0.000 description 1
JMUHBNWAORSSBD-WKYWBUFDSA-N mifamurtide Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O JMUHBNWAORSSBD-WKYWBUFDSA-N 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
239000003226 mitogen Substances 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
238000002156 mixing Methods 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
206010028417 myasthenia gravis Diseases 0.000 description 1
210000003098 myoblast Anatomy 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
230000002956 necrotizing effect Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
208000007538 neurilemmoma Diseases 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
230000036963 noncompetitive effect Effects 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
229940126578 oral vaccine Drugs 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
201000008482 osteoarthritis Diseases 0.000 description 1
201000008968 osteosarcoma Diseases 0.000 description 1
239000006179 pH buffering agent Substances 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
208000008443 pancreatic carcinoma Diseases 0.000 description 1
208000022102 pancreatic neuroendocrine neoplasm Diseases 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
230000000849 parathyroid Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 description 1
210000003899 penis Anatomy 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
108010021711 pertactin Proteins 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
210000003800 pharynx Anatomy 0.000 description 1
208000028591 pheochromocytoma Diseases 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
235000011007 phosphoric acid Nutrition 0.000 description 1
150000003016 phosphoric acids Chemical class 0.000 description 1
239000006187 pill Substances 0.000 description 1
229940031960 pneumococcal polysaccharide vaccine Drugs 0.000 description 1
108700004029 pol Genes Proteins 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920001515 polyalkylene glycol Polymers 0.000 description 1
229940115272 polyinosinic:polycytidylic acid Drugs 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
229940124959 polyvalent pneumococcal vaccine Drugs 0.000 description 1
230000015323 positive regulation of phagocytosis Effects 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
229960004919 procaine Drugs 0.000 description 1
230000002250 progressing effect Effects 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
229940097325 prolactin Drugs 0.000 description 1
210000002307 prostate Anatomy 0.000 description 1
108010043671 prostatic acid phosphatase Proteins 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
239000009342 ragweed pollen Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
230000008521 reorganization Effects 0.000 description 1
230000000284 resting effect Effects 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
201000005404 rubella Diseases 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
201000000306 sarcoidosis Diseases 0.000 description 1
210000001625 seminal vesicle Anatomy 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
239000002356 single layer Substances 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical group [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
208000028647 spindle cell neoplasm Diseases 0.000 description 1
229940031439 squalene Drugs 0.000 description 1
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
208000017572 squamous cell neoplasm Diseases 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
201000000498 stomach carcinoma Diseases 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
239000000758 substrate Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
239000003826 tablet Substances 0.000 description 1
229950008418 talipexole Drugs 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
229960003604 testosterone Drugs 0.000 description 1
229940118376 tetanus toxin Drugs 0.000 description 1
238000010257 thawing Methods 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
229940021747 therapeutic vaccine Drugs 0.000 description 1
208000008732 thymoma Diseases 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
206010043778 thyroiditis Diseases 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
XETCRXVKJHBPMK-MJSODCSWSA-N trehalose 6,6'-dimycolate Chemical compound C([C@@H]1[C@H]([C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C(CCCCCCCCCCC3C(C3)CCCCCCCCCCCCCCCCCC)C(O)CCCCCCCCCCCCCCCCCCCCCCCCC)O2)O)O1)O)OC(=O)C(C(O)CCCCCCCCCCCCCCCCCCCCCCCCC)CCCCCCCCCCC1CC1CCCCCCCCCCCCCCCCCC XETCRXVKJHBPMK-MJSODCSWSA-N 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
230000005740 tumor formation Effects 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
210000003932 urinary bladder Anatomy 0.000 description 1
229960005356 urokinase Drugs 0.000 description 1
238000003828 vacuum filtration Methods 0.000 description 1
206010046885 vaginal cancer Diseases 0.000 description 1
208000013139 vaginal neoplasm Diseases 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
201000010653 vesiculitis Diseases 0.000 description 1
230000017613 viral reproduction Effects 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
238000009736 wetting Methods 0.000 description 1
239000012224 working solution Substances 0.000 description 1